Wednesday, June 24, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 921 of 1,261
  1. US 8188072

    Benzodiazepinone compounds useful in the treatment of skin conditions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 29, 2012 · Expires May 24, 2032

    granted
  2. US 8188061

    RNAi modulation of APOB and uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  3. US 8188055

    Inactivators of O6-alkylguanine-DNA alkyltransferase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 29, 2012 · Expires May 24, 2032

    granted
  4. US 8188049

    Peptides having activities of epidermal growth factor and its uses

    CAREGEN CO., LTD. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  5. US 8188067

    Formulations of 6-mercaptopurine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  6. US 8188281

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  7. US 8188259

    Oligonucleotide-containing pharmacological compositions and their use

    Lakewood Amedex, Inc. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  8. US 8187605

    Means for the inhibition of anti-β1-adrenergic receptor antibodies

    Julius-Maximilians-Universitat Wurzburg · Granted May 29, 2012 · Expires May 24, 2032

    granted
  9. US 8187872

    Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein

    IMMUNE DESIGN CORP. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  10. US 8187606

    HPV antigen fusion protein vaccine compositions and uses thereof

    Beijing Sunbio Biotech Co. Ltd. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  11. US 8188071

    Amino substituted pyridines as potent kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  12. US 8188076

    Compositions, synthesis, and methods of utilizing arylpiperazine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  13. US 8188134

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  14. US 8188275

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 29, 2012 · Expires May 24, 2032

    granted
  15. US 8183207

    Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules

    Five Prime Therapeutics, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted
  16. US 8183358

    Puumala virus full-length M segment-based DNA vaccines

    The United States of America as represented by the Secretary of the Army · Granted May 22, 2012 · Expires May 17, 2032

    granted
  17. US 8183014

    High affinity antibodies to human IL-6 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted May 22, 2012 · Expires May 17, 2032

    granted
  18. US 8182836

    Abuse-resistant oral dosage forms and method of use thereof

    Elite Laboratories, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted
  19. US 8183012

    Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs

    The Regents of the University of California · Granted May 22, 2012 · Expires May 17, 2032

    granted
  20. US 8185186

    Systems and methods for tissue imaging

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 22, 2012 · Expires May 17, 2032

    granted
  21. US 8183373

    Solid state forms of sitagliptin salts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 22, 2012 · Expires May 17, 2032

    granted
  22. US 8183362

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted
  23. US 8183344

    Inactivation resistant factor VIII

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 22, 2012 · Expires May 17, 2032

    granted
  24. US 8183361

    Oligonucleotide-containing pharmacological compositions and their use

    Lakewood Amedex, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.